Bacillus coagulans SC-208 - Clinical Research Data Summary

Bacillus coagulans SC-208 Spore-Forming Probiotic Strain

Bacillus coagulans SC-208 is a clinically studied ingredient used in the following Silver Fern™ Brand product:

Introduction

Bacillus coagulans SC-208 is a spore-forming probiotic designed to provide reliable digestive support under real-world conditions where many traditional probiotics may struggle. As a naturally resilient bacterial spore, SC-208 can withstand heat, stomach acid, and digestive enzymes, allowing it to reach the small intestine intact where it can become metabolically active.*

Preclinical and mechanistic research on Bacillus coagulans strains shows they can support normal gut lining function, help maintain balanced immune signaling, and contribute to a healthy digestive environment. Unlike some probiotics that require strict storage conditions, SC-208's spore-based structure provides excellent stability, making it well suited for daily use and shelf-stable formulations.*

Rather than permanently colonizing the microbiome, SC-208 functions as a transient probiotic, passing through the digestive system while providing functional support along the way.*

These are the studies for Bacillus coagulans SC-208. Below, we provided a summary of each key data for each study, along with a link to the complete clinical research.

  1. Summary of Study 1 – Full Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC7409217/
  2. Summary of Study 2 – Full Study: https://pubmed.ncbi.nlm.nih.gov/21315976/

Ingredient Manufacturer Link: https://www.novonesis.com/en/biosolutions/human-health/dietary-supplements/gastrointestinal-health/b-coagulans-sc208



Study 1 Summary

Complete Study Information: https://pmc.ncbi.nlm.nih.gov/articles/PMC7409217/

In Vitro Research Evaluating Bacillus subtilis HU58 and Bacillus coagulans SC-208 (MegaDuo™) in a Simulated Gut Model
Marzorati, M. et al.

This controlled laboratory study evaluated a dual-strain spore-based probiotic formulation (MegaDuo™) containing B. subtilis HU58 and B. coagulans SC-208 using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) combined with a validated Caco-2/THP-1 intestinal cell co-culture model. Researchers examined how microbiome-derived metabolites influenced intestinal barrier function and immune signaling pathways under conditions representing both stable and disrupted microbial environments.

Study Design Highlights

  • Study type: In vitro mechanistic study using SHIME® + Caco-2/THP-1 epithelial–immune co-culture model
  • Model: Human fecal microbiota in simulated colon environment
  • Intervention: MegaDuo™ (B. subtilis HU58 + B. coagulans SC-208) at 2 × 10⁹ CFU/day equivalent
  • Duration: 2 weeks
  • Measured outcomes: Transepithelial electrical resistance (TEER), immune signaling molecules (TNF-α, IL-6, MCP-1, IL-8), NF-κB activity

Key Findings (What the Study Showed)

1. Support for Intestinal Barrier Function in the Model System

SHIME® supernatants from probiotic-treated vessels helped maintain epithelial barrier measurements (TEER) compared with untreated conditions. Effects were more pronounced after two weeks of exposure, suggesting time-dependent activity in the experimental system.

2. Changes in Immune Signaling Markers

Researchers observed differences in immune signaling molecules including TNF-α, IL-6, and MCP-1 in probiotic-treated model conditions compared with untreated controls.

3. Context-Dependent Effects

Under baseline conditions representing a stable microbiome, the probiotic produced relatively modest changes. Larger effects were observed in the model designed to simulate microbiome stress, suggesting the strains may interact with microbial environments differently depending on conditions.

4. No Direct Suppression of Core Immune Signaling

NF-κB signaling activity remained largely unchanged, suggesting that the observed effects were not associated with broad suppression of normal immune signaling pathways.

Benefits of B. coagulans SC-208 Demonstrated by This Study

Based directly on the in vitro findings, the B. coagulans SC-208-containing formulation was shown to:
✓ Support intestinal barrier measurements (TEER) in a simulated gut environment
✓ Influence immune signaling markers in a microbiome stress model
✓ Demonstrate time-dependent effects with greater activity at 2 weeks vs. 1 week
✓ Show context-dependent activity, with greater effects under microbiome stress conditions
✓ Maintain normal NF-κB signaling without broad immune suppression

Why This Study Matters

Because this research was conducted in laboratory models rather than human clinical trials, it provides mechanistic insight rather than direct evidence of health outcomes in people. These findings contribute to the broader scientific understanding of how spore-based probiotics may help support digestive system balance and normal gut function.*

Reference Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7409217/



Study 2 Summary

Complete Study Information: https://pubmed.ncbi.nlm.nih.gov/21315976/

Scientific Review on Bacillus Spore-Forming Probiotics
Dong, T.C., Van, P.H., Cutting, S.M. NutraFoods. 2009; 8(2):7–14.

This peer-reviewed scientific review examined the biological characteristics, safety considerations, and functional mechanisms of Bacillus spore-forming probiotics, summarizing decades of research on how Bacillus species differ from traditional probiotic organisms. Probiotic species reviewed include Bacillus subtilis, Bacillus clausii, Bacillus coagulans, and Bacillus licheniformis.

Key Insights from the Review

1. Exceptional Stability of Bacillus Spores

Bacillus probiotic spores are highly resilient structures capable of withstanding environmental stressors such as heat, moisture loss, and digestive conditions. Because of this stability, spore-forming probiotics can pass through the stomach and reach the intestine where they can become metabolically active.

2. Temporary Activity in the Digestive System

Unlike some probiotic organisms that may persist longer in the microbiome, Bacillus spores typically germinate temporarily in the small intestine before naturally passing through the digestive system. This transient activity allows them to interact with the digestive environment without permanently altering the microbiome.

3. Interaction With the Immune System

The review discusses research suggesting that germinating Bacillus spores may interact with gut-associated immune tissues and contribute to normal immune signaling processes in the digestive tract, supporting normal communication between the gut microbiome and the immune system.

4. Influence on Microbial Balance

Bacillus probiotics produce enzymes and metabolites that may influence the surrounding microbial environment, helping to support a balanced digestive ecosystem and healthy microbial diversity.

5. Safety of Well-Characterized Strains

Proper strain identification and manufacturing quality are critical for Bacillus probiotics. When well-studied strains are used, available toxicology studies, historical use data, and modern safety evaluations support their suitability for probiotic applications.

Benefits of B. coagulans SC-208 Supported by This Review

Based on the evidence summarized in this review, spore-forming Bacillus probiotics including B. coagulans were shown to:
✓ Demonstrate strong environmental and digestive stability through spore structure
✓ Reach the intestine in viable form for metabolic activity
✓ Provide temporary metabolic activity in the digestive tract without permanent colonization
✓ Interact with microbial and immune pathways in the gut
✓ Demonstrate established safety when properly strain-identified

Why This Review Matters

This publication helped clarify the scientific understanding of spore-based probiotics, explaining why Bacillus species behave differently from many traditional probiotic organisms. By describing their stability, temporary activity in the digestive tract, and interactions with the gut environment, the review provides a scientific framework for understanding how spore-forming probiotics may support digestive and microbial balance.*

Reference Link: https://pubmed.ncbi.nlm.nih.gov/21315976/

Big-Picture Integration with Other Studies

  • Study 1: Laboratory research using the SHIME® gut model plus an epithelial–immune co-culture system found that B. coagulans SC-208 (as part of MegaDuo™) was associated with maintained epithelial barrier measurements and changes in immune signaling markers (TNF-α, IL-6, MCP-1), with greater effects under microbiome stress conditions and without broad NF-κB suppression.
  • Study 2: A comprehensive scientific review describing the survivability, germination, immune system interactions, microbial balance support, and safety profile of spore-forming Bacillus probiotics including B. coagulans, providing the biological framework for SC-208's mechanism of action.

Together, these studies suggest that Bacillus coagulans SC-208 is a resilient, spore-forming probiotic that helps support normal gut barrier function and healthy immune system activity while naturally passing through the digestive system without permanently colonizing or dramatically altering the existing microbiome.*

Bacillus coagulans SC-208 Ingredient Summary & Real-World Relevance

Bacillus coagulans SC-208 is a spore-forming probiotic designed to provide reliable digestive support under real-world conditions where heat, stomach acid, and environmental stress can limit the stability of many traditional probiotics. As a durable bacterial spore, SC-208 can withstand harsh digestive conditions, allowing it to reach the small intestine where it can become metabolically active.*

Once active, SC-208 interacts with the digestive environment and naturally passes through the gastrointestinal tract without permanently colonizing the microbiome. Research on Bacillus coagulans and related spore-forming probiotics suggests they can help support normal gut barrier function, maintain microbial balance, and contribute to healthy immune system activity within the digestive tract.*

Because of its stability and transient activity in the gut, B. coagulans SC-208 is well suited for daily probiotic formulations designed to support digestive comfort, microbiome balance, and overall gut health. Its spore-based structure also makes it highly compatible with shelf-stable products and combination probiotic formulas.*

Ingredient Manufacturer Link: https://www.novonesis.com/en/biosolutions/human-health/dietary-supplements/gastrointestinal-health/b-coagulans-sc208

Bacillus coagulans SC-208 is a clinically studied ingredient used in the following Silver Fern™ Brand product:

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.